Bcl-2
Bcl-2 (BCL2 apoptosis regulator, also known as PPP1R50) is an integral outer mitochondrial membrane protein that suppresses apoptosis. It is the founding member of the Bcl-2 family and a central control point for cell survival in lymphocytes and other cell types. Browse Assay Genie's current range of Bcl-2 research reagents below, or read on for the biology behind the target.
Bcl-2 suppresses apoptosis in a variety of cell systems, including factor-dependent lymphohaematopoietic and neural cells. It regulates cell death by controlling mitochondrial membrane permeability and appears to function in a feedback loop with caspases. Bcl-2 inhibits caspase activity either by preventing the release of cytochrome c from mitochondria, by binding the apoptosis-activating factor APAF-1, or both.
Beyond apoptosis, Bcl-2 acts as an inhibitor of autophagy. During non-starvation conditions it interacts with BECN1 and AMBRA1 and inhibits their autophagy function. It may also attenuate inflammation by impairing NLRP1-inflammasome activation, and so CASP1 activation and IL1B release. The protein localises to the outer mitochondrial membrane, and is also found at the nuclear membrane, the endoplasmic reticulum membrane and in the cytoplasm.
The BCL2 gene is on chromosome 18 and belongs to the BCL2 family; HGNC also lists it among the protein phosphatase 1 regulatory subunits, hence the alias PPP1R50. Its earlier name, B-cell CLL/lymphoma 2, reflects its disease association. Constitutive expression of Bcl-2, as occurs when the gene is translocated to the Ig heavy chain locus, is thought to cause follicular lymphoma. Alternative splicing of the Bcl-2 gene produces multiple transcript variants. Mouse and rat both have a Bcl2 ortholog.
Bcl-2 controls mitochondrial membrane permeability and caspase activity, making it a key protein for studying how cells commit to or resist death.
Constitutive Bcl-2 expression after translocation to the Ig heavy chain locus is thought to cause follicular lymphoma.
Bcl-2 interacts with BECN1 and AMBRA1 under non-starvation conditions and inhibits their autophagy function.
Bcl-2 may attenuate inflammation by impairing NLRP1-inflammasome activation, CASP1 activation and IL1B release.
Bcl-2 suppresses apoptosis by controlling mitochondrial membrane permeability. It inhibits caspase activity by preventing cytochrome c release and/or by binding APAF-1. It also inhibits autophagy through BECN1 and AMBRA1, and may dampen NLRP1-inflammasome activation.
The HGNC symbol is BCL2, with the approved name BCL2 apoptosis regulator. Aliases and previous symbols include Bcl-2 and PPP1R50, and a previous name is B-cell CLL/lymphoma 2. Alternative splicing of the gene gives multiple transcript variants.
Constitutive BCL2 expression, such as after translocation to the Ig heavy chain locus, is thought to cause follicular lymphoma. Mouse and rat each have a Bcl2 ortholog; check the datasheet of any product for its validated reactivity.
Other Bcl-2 family members and BCL-named lymphoma-associated proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P10415; product specifications from Assay Genie datasheets.